Award

Rho-Kinase Pathway in Pulmonary Fibrosis

Description: RELEVANCE (See instructions): Idiopathic pulmonary fibrosis is a lethal disease ofthe lung with no effective therapies. This project evaluates the efficacy of a novel therapeutic approaches in an animal model of lung fibrosis that more closely resembles human IPF.
Funding type: program
Funder scheme: P50
Start date: 2011-05-01
End date: 2014-04-30
Field: Medicine
Funded outputs count: 11
Funder award ID: P50HL107181
OpenAlex ID: G6184450286
2017 · Qiang Ding, Indhu Subramanian, et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 33
2014 · Karen Bernard, Louise Hecker, et al. · Antioxidants and Redox Signaling · 114
2014 · Louise Hecker, Naomi J. Logsdon, et al. · Science Translational Medicine · 730
2014 · Yan Y. Sanders, James S. Hagood, et al. · European Respiratory Journal · 175
2013 · Victor J. Thannickal · Biogerontology · 120
2013 · Yong Zhou, Xiangwei Huang, et al. · Journal of Clinical Investigation · 488
2012 · Jeremy S. Duffield, Mark Lupher, et al. · Annual Review of Pathology Mechanisms of Disease · 687
2012 · Xiangwei Huang, Naiheng Yang, et al. · American Journal of Respiratory Cell and Molecular Biology · 588
2011 · Xiangwei Huang, Ying Gai, et al. · American Journal Of Pathology · 103
1999 · Bill Bramwell · Annals of tourism research en español